|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/7068 | (2006.01) |
| A61K 31/7072 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3917538 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20703447.1 |
| Date of filing the European patent application | 2020-02-03 | |
| (97) | Date of publication of the European application | 2021-12-08 |
| (45) | Date of publication and mention of the grant of the patent | 2023-07-12 |
| (46) | Date of publication of the claims translation | 2023-09-11 |
| (86) | Number | PCT/EP2020/052632 |
| Date | 2020-02-03 |
| (87) | Number | WO 2020/157335 |
| Date | 2020-08-06 |
| (30) | Number | Date | Country code |
| 201901427 | 2019-02-01 | GB |
| (72) |
ROBERTSON, Adam Brian , NO
PRIKRYLOVA, Terezia , NO
|
| (73) |
TETRAGON BIOSCIENCES LTD.,
Modi’in Technology Park, 2 HaMa’ayan Street, Modi’in, 7177871,
IL
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Deoksi-citidino dariniai, skirti panaudoti vėžio terapijose |
| DEOXY- CYTIDINE DERIVATIVES FOR USE IN CANCER THERAPIES |
| Payment date | Validity (years) | Amount | |
| 2026-01-21 | 7 | 162.00 EUR |
| 2027-02-03 |